Several recent studies have suggested that atypical antipsychotic medications such as risperidone can ameliorate certain cognitive deficits associated with schizophrenia.¹ Such findings have important implications, as cognitive impairment is a significant predictor of both social and occupational functioning in schizophrenia. In this issue, Burke and Reveley (pp 449–454)² show that patients treated with the atypical antipsychotic risperidone make fewer antisaccade errors than when they are treated …